| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/21/1994 | WO1994015586A1 Red blood cell surrogate |
| 07/21/1994 | WO1994015585A1 Human immunodeficiency virus decoy |
| 07/21/1994 | WO1994015581A1 Reduced and controlled surface binding of biologically active molecules |
| 07/21/1994 | WO1994015578A1 Anticaries compositions |
| 07/21/1994 | WO1994015466A1 Surrogate endocrine glands by genetic reassignment |
| 07/21/1994 | WO1994012648A3 Method for producing soluble t-receptors by co-transfection, and use of resulting products |
| 07/21/1994 | WO1994012639A3 Interleukin-3 (il-3) mutant polypeptides |
| 07/21/1994 | WO1994012537A3 Granulocyte chemotactic protein |
| 07/21/1994 | WO1994012534A3 Melanogenic inhibitor, and methods of producing and using the same |
| 07/21/1994 | WO1994012219A3 Modified insulin-like growth factors |
| 07/21/1994 | WO1994012144A3 Treatment of infertility and enhancement of fertilization capacity in mammalian males |
| 07/21/1994 | DE4400659A1 Prodn. of viral membrane protein domains |
| 07/21/1994 | CA2153967A1 Nf-atp, a t lymphocyte dna-binding protein |
| 07/21/1994 | CA2153654A1 Growth differentiation factor-5 |
| 07/21/1994 | CA2153652A1 Growth differentiation factor-3 |
| 07/21/1994 | CA2153486A1 Ras associated gap proteins |
| 07/21/1994 | CA2153409A1 Leukocyte derived growth factors |
| 07/21/1994 | CA2153241A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | CA2153228A1 Peptide inhibitors of cell adhesion |
| 07/21/1994 | CA2153147A1 Red blood cell surrogate |
| 07/21/1994 | CA2153065A1 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene |
| 07/21/1994 | CA2153051A1 Synthetic amphipathic peptides with antimicrobial activity |
| 07/21/1994 | CA2153046A1 Dna encoding a human betaine/gaba transporter and uses thereof |
| 07/21/1994 | CA2152934A1 Viral amplification of recombinant messenger rna in transgenic plants |
| 07/21/1994 | CA2152915A1 Antibodies directed against binding-associated epitopes |
| 07/21/1994 | CA2152818A1 Allergenic proteins and peptides from dog dander and uses therefor |
| 07/21/1994 | CA2152490A1 Human immunodeficiency virus decoy |
| 07/21/1994 | CA2152379A1 Reduced and controlled surface binding of biologically active molecules |
| 07/21/1994 | CA2152173A1 Method for breeding disease resistance into plants |
| 07/21/1994 | CA2151597A1 Process for the purification and refolding of human respiratory syncytial virus fg glycoprotein |
| 07/21/1994 | CA2150574A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 07/21/1994 | CA2149444A1 Anticaries compositions |
| 07/21/1994 | CA2131623A1 Prevention of suppression of immune defence against cancer caused by the cancer-associated scm-recognition peptides |
| 07/20/1994 | EP0607103A2 Somatostatin analogs containing chelating groups and their radiolabeled compositions |
| 07/20/1994 | EP0607080A1 New pro sequence for secretion of heterologous proteins from yeast cells |
| 07/20/1994 | EP0607054A2 Novel process for constructing a cDNA library and a novel polypeptide and DNA coding the same |
| 07/20/1994 | EP0606921A1 Method of isolating haemophilus influenzae protein E |
| 07/20/1994 | EP0606917A2 A methylotropic and glucotropic mutant strain for producing a heterologous protein |
| 07/20/1994 | EP0606816A1 Procedure for preparing salmon calcitonin |
| 07/20/1994 | EP0606734A1 Human CNS receptors of the NMDA-R1 family |
| 07/20/1994 | EP0606683A2 Means for diagnosis of angiogenic diseases |
| 07/20/1994 | EP0606673A2 Controlled oxidation of microbially produced cysteine-containing proteins |
| 07/20/1994 | EP0606518A1 Intercellular adhesion molecules and their binding ligands |
| 07/20/1994 | EP0606464A1 Peptides capable of controlling acrosome reaction |
| 07/20/1994 | EP0606463A1 Neuromedin b receptor antagonists |
| 07/20/1994 | EP0606452A1 Vector vaccines of recombinant feline herpesvirus |
| 07/20/1994 | EP0606437A1 Non-shedding live herpesvirus vaccine |
| 07/20/1994 | EP0606411A1 Novel compounds and conjugates |
| 07/20/1994 | EP0606376A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
| 07/20/1994 | EP0606217A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 07/20/1994 | EP0536290B1 Method and device for obtaining beta casein |
| 07/20/1994 | EP0522086B1 DNA SEQUENCE ENCODING GALACTOPROTEIN b3 |
| 07/20/1994 | EP0484406B1 Polypeptide inhibitor of viral replication |
| 07/20/1994 | EP0378641B1 Novel antimicrobial peptide, compositions containing same and uses thereof |
| 07/20/1994 | EP0366777B1 Stimulation of chemotaxis by chemotactic peptides |
| 07/20/1994 | EP0362283B1 Bovine interleukin-1 alpha |
| 07/20/1994 | EP0209568B1 Dna sequences, recombinant dna molecules and processes for producing human lipocortin-like polypeptides |
| 07/20/1994 | CN1089660A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for......... |
| 07/20/1994 | CA2113695A1 Fibrinogen processing apparatus, method and container |
| 07/19/1994 | US5331109 Phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels |
| 07/19/1994 | US5331095 Ion exchanging, hydrophobic interaction chromatography |
| 07/19/1994 | US5331094 Purified active somatostatin receptor |
| 07/19/1994 | US5331091 Tyrosinase inhibitors in pigment cells; skin whitening |
| 07/19/1994 | US5331090 CR2 ligand compositions and methods for modulating immune cell functions |
| 07/19/1994 | US5330975 Bacterial toxin neutralizer |
| 07/19/1994 | US5330974 Therapeutic fibrinogen compositions |
| 07/19/1994 | US5330971 Insulin-like growth factor I, genetic engineering |
| 07/19/1994 | US5330910 Immunoassay |
| 07/19/1994 | US5330902 DNA encoding a helical polypeptide attached to a gene endcoding a protein spontaneously forms inclusion bodies; purification and cleavage to separate amphilic helix from product |
| 07/19/1994 | US5330901 Expression of human serum albumin in Pichia pastoris |
| 07/19/1994 | US5330897 Sialic acid binding lectin of protozoan origin |
| 07/19/1994 | US5330896 Monoclonal antibodies to an autocrine growth factor antigen that binds to activated lymphocytes and cancer cells |
| 07/19/1994 | US5330895 Detection reagent and antibody specific for dopamine releasing protein |
| 07/19/1994 | US5330892 MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans |
| 07/19/1994 | US5330754 Membrane-associated immunogens of mycobacteria |
| 07/19/1994 | US5330753 Cholera vaccines |
| 07/19/1994 | US5330682 Methods of emulsification with peptide emulsifiers |
| 07/19/1994 | CA1330800C Specific peptide bond cleavage by organic tertiary phosphines with nucleophilic side chains |
| 07/19/1994 | CA1330768C Monoclonal anti-human granulocyte colony stimulating factor antibody |
| 07/19/1994 | CA1330757C Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
| 07/15/1994 | CA2381458A1 Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 07/14/1994 | DE4300649A1 Ionotropic gel contg. oriented radiation-sensitive bio-molecules |
| 07/14/1994 | DE4300222A1 Calf thymus cell nuclei phospho peptide of approximately 9950 daltons |
| 07/14/1994 | CA2113245A1 Agents for the diagnosis of vascular diseases |
| 07/13/1994 | EP0606110A1 Method of enhancing the insecticidal activity of an insecticidal composition containing a coleopteran-toxic protein |
| 07/13/1994 | EP0605983A2 Insulin analogs |
| 07/13/1994 | EP0605963A2 Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof |
| 07/13/1994 | EP0605797A1 Synthetic peptides, antibodies directed against them and their use |
| 07/13/1994 | EP0605789A1 Characterization of oncogenes and assays based thereon |
| 07/13/1994 | EP0605680A1 Infectious bovine rhinotracheitis virus mutants and vaccines |
| 07/13/1994 | EP0605653A1 A new form of liposaccharide binding protein (lbp) |
| 07/13/1994 | EP0605629A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies and method of use |
| 07/13/1994 | EP0605627A1 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 07/13/1994 | EP0605586A1 Process for controlling lepidopteran pests |
| 07/13/1994 | EP0605561A1 Annexin xi |
| 07/13/1994 | EP0605522A1 Production of chimeric antibodies - a combinatorial approach |
| 07/13/1994 | EP0605489A1 Modified peptide derivatives |
| 07/13/1994 | EP0605484A1 Peptides having growth hormone releasing activity |
| 07/13/1994 | EP0605442A1 Recombinant antibodies for human therapy |
| 07/13/1994 | EP0605432A1 Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |